RBN013209

CAS No. 2597933-17-8

RBN013209( —— )

Catalog No. M28545 CAS No. 2597933-17-8

RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 Get Quote
5MG 149 Get Quote
10MG 231 Get Quote
25MG 446 Get Quote
50MG 623 Get Quote
100MG 880 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RBN013209
  • Note
    Research use only, not for human use.
  • Brief Description
    RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
  • Description
    RBN013209 is a potent CD38 inhibitor. RBN013209 is useful in the treatment of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    cPLA2α|Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2597933-17-8
  • Formula Weight
    384.43
  • Molecular Formula
    C19H24N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (260.13 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nakamura H, et al. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004 Jan 19;484(1):9-17.
molnova catalog
related products
  • 1H-Purine-2,6-dione

    TH5427 hydrochloride is a potent, selective NUDT5 inhibitor (IC50=29 nM). TH5427 hydrochloride shows an apparent 690-fold selectivity for NUDT5 over MTH1. TH5427 hydrochloride blocks progestin-dependent, PAR-derived nuclear ATP synthesis and subsequent chromatin remodeling, gene regulation and proliferation in breast cancer cells.

  • Vercirnon

    Vercirnon is a selective and potent antagonist of CCR9 (IC50: 10 nM). It is also used in the research of inflammatory bowel diseases.

  • Pratensein

    Pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells.